TherapeuticsMD (NASDAQ:TXMD) reported its Q3 earnings results on Thursday, November 11, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
TherapeuticsMD their estimated earnings by 10.0%, reporting an EPS of $-0.11 versus an estimate of $-0.1, which did not surprise analysts.
Revenue was up $6,064,000 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0, which was followed by a 3.07% increase in the share price the next day.
Here's a look at TherapeuticsMD's past performance:
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
